Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
female (14) 14
index medicus (14) 14
middle aged (12) 12
adult (11) 11
male (9) 9
surgery (8) 8
aged (7) 7
oncology (7) 7
mortality (6) 6
astrophysics - solar and stellar astrophysics (5) 5
disease-free survival (5) 5
physics - solar and stellar astrophysics (5) 5
survival (5) 5
astronomy & astrophysics (4) 4
breast neoplasms - drug therapy (4) 4
breast neoplasms - pathology (4) 4
chemistry, inorganic & nuclear (4) 4
dioxide (4) 4
neoplasm staging (4) 4
patients (4) 4
postoperative care/methods (4) 4
postoperative care/statistics and numerical data (4) 4
prospective studies (4) 4
simulation (4) 4
treatment outcome (4) 4
uranium (4) 4
accretion, accretion disks (3) 3
administration, oral (3) 3
aged, 80 and over (3) 3
antibiotics (3) 3
antineoplastic agents - therapeutic use (3) 3
breast neoplasms - mortality (3) 3
cancer (3) 3
cataclysmic variables (3) 3
chemotherapy (3) 3
cohort studies (3) 3
critical care/utilisation (3) 3
defects (3) 3
europe (3) 3
fungi (3) 3
hospitals (3) 3
infectious diseases (3) 3
kaplan-meier estimate (3) 3
metastasis (3) 3
microbiology (3) 3
novae, cataclysmic variables (3) 3
operative/mortality (3) 3
oxidation (3) 3
pharmacology & pharmacy (3) 3
population (3) 3
program (3) 3
reaction sites (3) 3
stability (3) 3
stars: dwarf novae (3) 3
stars: individual (3) 3
surgical procedures (3) 3
ab-initio-berechnung (2) 2
ab-initio-calculation (2) 2
abridged index medicus (2) 2
accretion (2) 2
accretion disks (2) 2
actinide (2) 2
actinoids (2) 2
air filtration (2) 2
analysis (2) 2
anesthesiology (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
astrophysics (2) 2
breast cancer (2) 2
breast neoplasms (2) 2
cefazolin - blood (2) 2
cells (2) 2
checklist (2) 2
chemistry, physical (2) 2
clinical medicine (2) 2
clinical-trials (2) 2
clusters (2) 2
collaboration (2) 2
critical care (2) 2
crystal-structure (2) 2
data processing (2) 2
diffusion (2) 2
diffusivity (2) 2
diffusivität (2) 2
dislocations (2) 2
dose-response relationship, drug (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
elastic properties (2) 2
energy & fuels (2) 2
ethics (2) 2
filters (2) 2
filtration (2) 2
follow-up (2) 2
follow-up studies (2) 2
food science & technology (2) 2
growth (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
ExteNET showed that 1 year of neratinib, an irreversible pan-HER tyrosine kinase inhibitor, significantly improves 2-year invasive disease-free survival after... 
LAPATINIB | NCCTG N9831 | NSABP B-31 | HERA TRIAL | MULTICENTER | ONCOLOGY | TYROSINE KINASE | FOLLOW-UP | JOINT ANALYSIS | ESTROGEN-RECEPTOR | CHEMOTHERAPY | Breast Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Quinolines - administration & dosage | Dose-Response Relationship, Drug | Time Factors | Neoplasm Invasiveness - pathology | Adult | Female | Chemotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Administration, Oral | Japan | Kaplan-Meier Estimate | Proportional Hazards Models | Trastuzumab - adverse effects | Treatment Outcome | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Neoplasm Staging | Quinolines - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy
by Thomas, H.S and Weiser, T.G and Drake, T.M and Knight, S.R and Fairfield, C and Ademuyiwa, A.O and Aguilera, M.L and Alexander, P and Al-Saqqa, S.W and Borda-Luque, G and Costas-Chavarri, A and Ntirenganya, F and Fitzgerald, J.E and Fergusson, S.J and Glasbey, J and Ingabire, J.C.A and Ismaïl, L and Salem, H.K and Kojo, A.T.T and Lapitan, M.C and Lilford, R and Mihaljevic, A.L and Morton, D and Mutabazi, A.Z and Nepogodiev, D and Adisa, A.O and Ots, R and Pata, F and Pinkney, T and Qureshi, A.U and la Medina, A.R and Rayne, S and Shaw, C.A and Shu, S and Spence, R and Smart, N and Tabiri, S and Bhangu, A and Harrison, E.M and Verjee, A and Runigamugabo, E and Altamini, A and Cornick, J and Jaffry, Z and Khatri, C and Kirby, A and Mohan, M and Recinos, G and Søreide, K and Gobin, N and Freitas, A.V and Hall, N and Kim, S.H and Negida, A and Khairy, H and Chapman, S.J and Arnaud, A.P and Manipal, C.E and Amandito, R and Shawki, M and Hanrahan, M and Zilinskas, J and Roslani, A.C and Goh, C.C and Irwin, G and Luque, L and Shiwani, H and Altamimi, A and Alsaggaf, M.U and Jeyakumar, J and Cengiz, Y and Raptis, D.A and Glasbey, J.C and Modolo, M.M and Iyer, D and King, S and Arthur, T and Nahar, S.N and Waterman, A and Walsh, L.I and Agarwal, A and Zani, A and Firdouse, M and Rouse, T and Liu, Q and Correa, J.C and Talving, P and Worku, M and Arnaud, A and Kalles, V and Kumar, B and Kumar, S and Quek, R and Ansaloni, L and Altibi, A and Venskutonis, D and Poskus, T and Whitaker, J and Msosa, V and Tew, Y.Y and ... and GlobalSurg Collaborative
British Journal of Surgery, ISSN 0007-1323, 01/2019, Volume 106, Issue 2, pp. e103 - e112
WHO Surgical Safety checklist use in emergency laparotomy was associated with a significantly lower perioperative mortality, yet its use in low‐HDI countries... 
SURGERY | IMPLEMENTATION | BARRIERS | HEALTH | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights